NT-Pro-BNP and echocardiography for the early assessment of cardiovascular dysfunction in neonates with sepsis

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To investigate the predictive manner of N-terminal fragment of brain natriuretic peptide (NT-Pro-BNP) and echocardiography in the early assessment of cardiovascular dysfunction (CVD) in neonates with sepsis, we recruited 108 neonates with sepsis in intensive care units and divided them into a sepsis with CVD (sepsis + CVD) group (n = 48) and a sepsis only group (n = 60). Neonates with other infections (n = 65) constituted the control group. Clinical, laboratory, and bedside echocardiography findings were evaluated. Compared to both the sepsis only and control groups, the sepsis + CVD group showed an earlier onset of symptoms [52.94 (0-185.6) h], higher NT-Pro-BNP levels (P =.02), a higher Tei index (0.52 + 0.03; P =.03), and lower ejection fraction (62.61% ± 12.31%, P

Cite

CITATION STYLE

APA

Yang, C., Ma, J., Guo, L., Li, B., Wang, L., Li, M., … Zhao, C. (2022). NT-Pro-BNP and echocardiography for the early assessment of cardiovascular dysfunction in neonates with sepsis. Medicine (United States), 101(37), E30439. https://doi.org/10.1097/MD.0000000000030439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free